U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Chronic myelogenous leukemia, BCR-ABL1 positive

Summary

A myeloproliferative disorder characterized by increased proliferation of the granulocytic cell line without the loss of their capacity to differentiate. [from HPO]

Genes See tests for all associated and related genes

  • Also known as: ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl, ABL1
    Summary: ABL proto-oncogene 1, non-receptor tyrosine kinase

  • Also known as: ALL, BCR1, CML, D22S11, D22S662, PHL, BCR
    Summary: BCR activator of RhoGEF and GTPase

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.